Johnson Matthey Inc. recalls Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West
Johnson Matthey recalls Fentanyl Citrate Active Pharmaceutical Ingredient due to potential glass contamination from cGMP deviations. Affected lots expire Feb 2023.
Recall notice
cGMP Deviations: Potential glass contamination
Contact the company & request your remedy
What happened, in plain English
Johnson Matthey is recalling Fentanyl Citrate Active Pharmaceutical Ingredient because of potential glass contamination during manufacturing. This could affect drug safety if the contamination occurs. Read more at govinfonow.com/recall/38063-johnson-matthey-fentanyl-citrate-apg-recall-potential-glass-contamination-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/38063-johnson-matthey-fentanyl-citrate-apg-recall-potential-glass-contamination-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1880-2019
Cite this page
“Johnson Matthey Fentanyl Citrate APG Recall: Potential Glass Contamination Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38063-johnson-matthey-fentanyl-citrate-apg-recall-potential-glass-contamination-risk. Based on FDA recall #D-1880-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1880-2019%22&limit=1).
Why it’s dangerous
The recall is due to potential glass contamination in the manufacturing process, which could occur during the production of the Fentanyl Citrate Active Pharmaceutical Ingredient. This contamination might lead to unsafe drug products if not properly detected.
Who’s affected
Pharmacies and manufacturers using the recalled Fentanyl Citrate Active Pharmaceutical Ingredient for drug production are likely affected. Those handling the specific lots with lot numbers B0030-180101 or B0030-180102 are at risk.
How to tell if you have this one
Check for lot numbers B0030-180101 or B0030-180102 on the Fentanyl Citrate Active Pharmaceutical Ingredient. The product was manufactured by Johnson Matthey Inc. and expires February 2023.
- Brand
Johnson Matthey- Category
Drug
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide within the United States
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1880-2019 | Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001.; Lot #: B0030-180101, B0030-180102, Exp. Feb 2023 | 52882.23 grams |
| D-1881-2019 | Cisplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001; Lot #: B0101-161102, Exp. Dec 2021 | 26625 grams |
| D-1882-2019 | Oxaliplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001, NDC 49821-0075-XX; Lot #: B0126-170701; B0126-170802; Exp. Sep 2022; B0126-180401, Exp. May 2023; B0126-180702, B0126-180803, Exp. Oct 2023 | 316703.32 |
What to do — step by step
Check Lot Numbers
Look for lot numbers B0030-180101 or B0030-180102 on the Fentanyl Citrate Active Pharmaceutical Ingredient.
Questions people ask
What is the hazard with this product?
The recall is due to potential glass contamination from cGMP deviations during manufacturing.
What should I do if I have this product?
Check the lot numbers on the product; if they are B0030-180101 or B0030-180102, contact Johnson Matthey at (856) 384-7001.
Is there a deadline to act?
The official recall notice does not specify a deadline for action.
Contact Johnson Matthey
We’ve drafted a message you can send Johnson Matthey to request your refund or repair — edit it as you like.
Subject: Recall D-1880-2019 — Johnson Matthey Johnson Matthey Hello, I own a Johnson Matthey that is covered by recall D-1880-2019 from Johnson Matthey. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1880-2019 (August 29, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1880-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.